The Hanover Insurance Group, Inc. announced a planned CEO succession. President and CEO John C. Roche will retire as CEO and board member effective December 31, 2026, following a 40-year career in the insurance industry, and will remain in an advisory role through January 8, 2027.
The board has appointed Richard W. Lavey, currently executive vice president and chief operating officer, as CEO-Elect, with the intent to make him CEO upon Roche’s retirement and to elect him to the board effective January 1, 2027. The company states that Roche’s retirement is not related to any disagreement over its operations, policies, or practices, and plans to address the transition on a July 29, 2026 earnings call and at an investor day on September 17, 2026.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director Kathy S. Lane reported a small equity award. She received 3.767 shares of common stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan, tied to dividend equivalent rights on previously granted RSUs.
After this grant, Lane holds 2,772.767 shares of common stock directly. Footnotes state the award will vest on the earlier of one year from the original RSU grant date or the next annual meeting, and that she has elected to defer the grant upon vesting under a deferral agreement. The disclosure also notes an additional 4,829 shares held indirectly in a Rabbi Trust pursuant to deferral agreements.
Hanover Insurance Group director Cynthia Egan reported a small equity award linked to prior grants. She acquired 3.767 shares of common stock through dividend-equivalent restricted stock units under the company’s 2022 Long-Term Incentive Plan. After this award, she directly holds 10,205.767 common shares, with additional shares held indirectly in a Rabbi Trust.
HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an acquisition of common stock tied to her equity compensation. She received 3.767 restricted stock units (RSUs) on June 26, 2026 at a stated price of $0.00 per share, increasing her directly held common stock to 3,269.767 shares.
The RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights on previously granted RSUs. These units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. Footnotes also note 2,306 additional shares held indirectly in a Rabbi Trust pursuant to deferral agreements.
Bunting Theodore H JR reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Theodore H. Bunting Jr. received a grant of 3.767 restricted stock units as a dividend equivalent under the company’s 2022 Long-Term Incentive Plan. These units vest on the earlier of the one-year anniversary of the original RSU grant or the next annual meeting, bringing his direct holdings to 7,034.767 common shares.
Donnell William E. reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director William E. Donnell reported a small equity award rather than an open-market trade. He received 3.767 restricted stock units as dividend-equivalent credits under the company’s 2022 Long-Term Incentive Plan, tied to RSUs previously granted. These units vest on the earlier of the one-year anniversary of the original RSU grant or the next annual meeting. Following this award, he holds 846.767 common shares directly, and a footnote states that a further 977 shares are held indirectly in a Rabbi Trust under deferral agreements.
Hanover Insurance Group director Kevin Bradicich received a small equity award. He was granted 3.767 shares of common stock in the form of restricted stock units connected to dividend equivalent rights under the company’s 2022 Long-Term Incentive Plan.
These units vest on the earlier of the one-year anniversary of the original RSU grant date or the date of the next annual meeting. After this award, Bradicich directly holds a total of 10,095.767 common shares. This is a routine, compensation-related acquisition rather than an open-market purchase.
Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Francisco Aristeguieta reported a small equity compensation update. He received 3.767 shares of common stock in the form of restricted stock units granted at no cash cost under the company’s 2022 Long-Term Incentive Plan.
These RSUs were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. Following this grant, Aristeguieta directly holds a total of 4,056.767 common shares, reflecting a routine, compensation-related accrual rather than an open-market purchase or sale.
Hanover Insurance Group director J. Paul Condrin received a small equity-based award. On June 26, 2026, he acquired 3.767 shares of common stock at $0.00 per share through a grant of restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The grant reflects dividend equivalent rights tied to RSUs previously awarded under the same plan. Following this award, Condrin directly holds 6,355.767 shares of Hanover Insurance Group common stock. The new units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting.
HANOVER INSURANCE GROUP, INC. director Joseph R. Ramrath received a small equity-based compensation award. He acquired 3.767 shares of Common Stock in the form of restricted stock units granted at no cash cost, tied to dividend equivalent rights on previously granted RSUs under the 2022 Long-Term Incentive Plan.
These additional units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. After this award, Ramrath directly holds a total of 33,833.767 shares of Common Stock. The transaction reflects routine compensation rather than an open-market trade.